{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:39:17Z","timestamp":1759365557734,"version":"build-2065373602"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.7759\/cureus.93633","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:13:53Z","timestamp":1759310033000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Splenic Follicular Lymphoma Presenting As Isolated Splenomegaly: A Case Report"],"prefix":"10.7759","author":[{"given":"Pranavi","family":"Indukuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pulkit","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri Gayathri","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028539","article-title":"Characteristics and survival outcomes of primary splenic cancers: a SEER population-based study","volume":"101","author":"Lei Y","year":"2022","unstructured":"Lei Y, Huang Q, Li X, Zheng X, Liu M. Characteristics and survival outcomes of primary splenic cancers: a SEER population-based study. Medicine (Baltimore). 2022, 101:e28539. 10.1097\/MD.0000000000028539","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24945","article-title":"Acute immune toxicity during anti-thymocyte globulin: that's CARPA!","volume":"93","author":"Marotta S","year":"2018","unstructured":"Marotta S, Ricci P, Marano L, et al.. Acute immune toxicity during anti-thymocyte globulin: that's CARPA!. Am J Hematol. 2018, 93:E22-E24. 10.1002\/ajh.24945","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2019.1613770","article-title":"Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base","volume":"24","author":"Fallah J","year":"2019","unstructured":"Fallah J, Olszewski AJ. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base. Hematology. 2019, 24:378-386. 10.1080\/16078454.2019.1613770","journal-title":"Hematology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28060407","article-title":"Low-grade primary splenic CD10-positive small B-cell lymphoma\/follicular lymphoma","volume":"28","author":"Abdulbaki R","year":"2021","unstructured":"Abdulbaki R, Tizro P, Nava VE, Gomes da Silva M, Ascens\u00e3o JL. Low-grade primary splenic CD10-positive small B-cell lymphoma\/follicular lymphoma. Curr Oncol. 2021, 28:4821-4831. 10.3390\/curroncol28060407","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318193fcef","article-title":"Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases","volume":"33","author":"Mollejo M","year":"2009","unstructured":"Mollejo M, Rodr\u00edguez-Pinilla MS, Montes-Moreno S, et al.. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases. Am J Surg Pathol. 2009, 33:730-738. 10.1097\/PAS.0b013e318193fcef","journal-title":"Am J Surg Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.06.012","article-title":"Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes","volume":"44","author":"Naemi K","year":"2013","unstructured":"Naemi K, Brynes RK, Reisian N, et al.. Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes. Hum Pathol. 2013, 44:512-520. 10.1016\/j.humpath.2012.06.012","journal-title":"Hum Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/EG2M-YHB9-WEFW-7H1R","article-title":"Follicular pattern of bone marrow involvement by follicular lymphoma","volume":"118","author":"Torlakovic E","year":"2002","unstructured":"Torlakovic E, Torlakovic G, Brunning RD. Follicular pattern of bone marrow involvement by follicular lymphoma. Am J Clin Pathol. 2002, 118:780-786. 10.1309\/EG2M-YHB9-WEFW-7H1R","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S120589","article-title":"Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape","volume":"9","author":"Subramanian J","year":"2017","unstructured":"Subramanian J, Cavenagh J, Desai B, Jacobs I. Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape. Cancer Manag Res. 2017, 9:131-140. 10.2147\/CMAR.S120589","journal-title":"Cancer Manag Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374092-primary-splenic-follicular-lymphoma-presenting-as-isolated-splenomegaly-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:13:53Z","timestamp":1759310033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374092-primary-splenic-follicular-lymphoma-presenting-as-isolated-splenomegaly-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.93633","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}